Market News AIOpen the app

IMMP stock news · Immutep Limited

Stories about Immutep Limited (IMMP) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IMMP

Follow Immutep Limited (IMMP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IMMP
Free on the App Store and Google Play, or on the web.
  1. Nov 11, 2026, 11:33 AM ET · Trial

    Immutep Reports Encouraging Survival Data From Phase 2 Cancer Trial

    Good for IMMP

    Immutep reported 81.1% disease-free survival at 12 months and received U.S. patent protection through 2038. These findings are encouraging, despite an earlier lung-cancer trial ending early.